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 2 
Abstract 16 
 17 
Enzymes of the AlkB and CYP153 families catalyze the first step in the 18 
catabolism of medium chain-length alkanes, selective oxidation of the alkane to the 1-19 
alkanol, and enable their host organisms to utilize alkanes as carbon sources. Small, 20 
gaseous alkanes, however, are converted to alkanols by evolutionarily unrelated methane 21 
monooxygenases (MMO). Propane and butane can be oxidized by CYP enzymes 22 
engineered in the laboratory, but these produce predominantly the 2-alkanols. Here we 23 
report the in vivo directed evolution of two medium chain-length terminal alkane 24 
hydroxylases, the integral-membrane di-iron enzyme AlkB from Pseudomonas putida 25 
GPo1 and the class II type soluble CYP153A6 from Mycobacterium sp. HXN-1500, to 26 
enhance their activity on small alkanes. We established a P. putida evolution system that 27 
enables selection for terminal alkane hydroxylase activity and used it to select propane- 28 
and butane-oxidizing enzymes based on enhanced growth complementation of an adapted 29 
P. putida GPo12 (pGEc47∆B) strain. The resulting enzymes exhibited higher rates of 1-30 
butanol production from butane and maintained their preference for terminal 31 
hydroxylation. This in vivo evolution system could be useful for directed evolution of 32 
enzymes that function efficiently to hydroxylate small alkanes in engineered hosts.33 
ACC
EPT
ED
 3 
Introduction 34 
 35 
Microbial utilization and degradation of alkanes was discovered almost a century ago 36 
(27). Since then, several enzyme families capable of hydroxylating alkanes to alkanols, 37 
the first step in alkane degradation, have been identified and categorized based on their 38 
preferred substrates (30). The soluble and particulate methane monooxygenases (sMMO, 39 
pMMO) and the related propane and butane monooxygenases (PMO, BMO) are 40 
specialized on gaseous small-chain alkanes (C1-C4), while medium-chain (C5-C16) alkane 41 
hydroxylation seems to be the domain of the CYP153 and AlkB enzyme families.  42 
Conversion of C1-C4 alkanes to alkanols is of particular interest for producing 43 
liquid fuels or chemical precursors from natural gas. The MMO-like enzymes that 44 
catalyze this reaction in nature, however, exhibit limited stability or poor heterologous 45 
expression (30) and have not been suitable for use in a recombinant host that can be 46 
engineered to optimize substrate or cofactor delivery. Alkane monooxygenases often co-47 
metabolize a wider range of alkanes than those which support growth (12). We wished 48 
to determine whether it is possible to engineer a medium-chain alkane monooxygenase 49 
to hydroxylate small alkanes, thereby circumventing difficulties associated with 50 
engineering MMO-like enzymes as well as investigating the fundamental question of 51 
whether enzymes unrelated to MMO can support growth on small alkanes.  52 
The most intensively studied medium-chain alkane hydroxylases are the AlkB 53 
enzymes (2, 20, 29), especially AlkB from Pseudomonas putida GPo1 (13, 32, 35, 28). 54 
While most members of the AlkB family act on C10 or longer alkanes, some accept 55 
alkanes as small as C5 (10). A recent study (12) indicated that AlkB from P. putida GPo1 56 
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may also be involved in propane and butane assimilation.  AlkB selectively oxidizes at 57 
the terminal carbon to produce the 1-alkanols. No systematic protein engineering studies 58 
have been conducted on this di-iron integral-membrane enzyme, although selection and 59 
site-directed mutagenesis efforts identified one amino acid residue that sterically 60 
determines long-chain alkane degradation (35). 61 
The most recent addition to the known biological alkane-hydroxylating repertoire 62 
is the CYP153 family of heme-containing cytochrome P450 monooxygenases. Although 63 
their activity was detected as early as 1981 (1), the first CYP153 was characterized only 64 
in 2001 (16). Additional CYP153 enzymes were identified and studied more recently (31, 65 
9, 10). These soluble class II type three-component P450 enzymes and the AlkB enzymes 66 
are the main actors in medium chain-length alkane hydroxylation by the cultivated 67 
bacteria analyzed to date (31). CYP153 monooxygenases have been the subject of 68 
biochemical studies (18, 16, 9), and their substrate range has been explored (14, 10).  69 
Known substrates include C5-C11 alkanes. The best characterized member, CYP153A6, 70 
hydroxylates its preferred substrate octane predominantly (>95%) at the terminal position 71 
(9).  72 
Recent studies have shown that high activities on small alkanes can be obtained 73 
by engineering bacterial P450 enzymes such as P450cam (CYP101, camphor 74 
hydroxylase) and P450 BM3 (CYP102A, a fatty acid hydroxylase) (36, 8).  The resulting 75 
enzymes, however, hydroxylate propane and higher alkanes primarily at the more 76 
energetically favorable sub-terminal positions;  highly selective terminal hydroxylation is 77 
difficult to achieve by engineering a sub-terminal hydroxylase (22). We wished to 78 
determine whether a small-alkane terminal hydroxylase could be obtained instead by 79 
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directed evolution of a longer-chain alkane hydroxylase that exhibits this desirable 80 
regioselectivity.  For this study, we chose to engineer AlkB from P. putida GPo1 and 81 
CYP153A6 from Mycobacterium sp. HXN-1500 (33, 9) to enhance activity on butane. 82 
Because terminal alkane hydroxylation is the first step of alkane catabolism in P. putida 83 
GPo1, we reasoned that it should be possible to establish an in vivo evolution system that 84 
uses growth on small alkanes to select for enzyme variants exhibiting the desired 85 
activities.  86 
The recombinant host Pseudomonas putida GPo12 (pGEc47∆B) was engineered 87 
specifically for complementation studies with terminal alkane hydroxylases and was used 88 
previously to characterize members of the AlkB and CYP153 families (26, 31). This 89 
strain is a derivative of the natural isolate P. putida GPo1 lacking its endogenous OCT-90 
plasmid (octane assimilation, 5), but containing cosmid pGEc47∆B, which carries all 91 
genes comprising the alk machinery necessary for alkane utilization, with the exception 92 
of a deleted alkB gene (34). We show that this host can be complemented by a plasmid-93 
encoded library of alkane hydroxylases and that growth of the mixed culture on butane 94 
leads to enrichment of novel butane-oxidizing terminal hydroxylases.  95 
 96 
Materials and Methods 97 
 98 
Strains and growth conditions. The strains and plasmids used in this study are 99 
listed in Table 1. Luria-Bertani broth (23) and modified M9 medium with 1.5% yeast 100 
extract (8) supplemented with appropriate antibiotics, or E2 (15) and M9 (17) minimal 101 
media supplemented with carbon sources were used for growth. All cultures were grown 102 
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aerobically at 30°C (P. putida) or 37°C (E. coli). Antibiotic concentrations were 100 103 
µg/ml ampicillin, 15 µg/ml tetracycline, 20 µg/ml chloramphenicol, and 10 µg/ml 104 
gentamicin for E. coli cultures or 50 µg/ml for Pseudomonads. Bacterial strains were 105 
grown on solid E2 minimal medium with liquid alkanes (Sigma-Aldrich) provided 106 
through the gas phase as described previously (26). Solid minimal media growth tests on 107 
gaseous alkanes (Sigma-Aldrich) were conducted in gas-tight plastic containers (GasPak 108 
150 Large Anaerobic Vented System, VWR), pressurized at 20 psi for 20 s (ethane, 109 
propane) or 10 psi for 6 s (butane). Liquid minimal media cultures growing on alkanes 110 
were shaken in custom-made gas-tight flasks with 1% liquid alkane (pentane, octane) in a 111 
reservoir, or gas-tight serum bottles (Alltech), pressurized with gaseous alkanes as 112 
described above. For growth tests of P. putida GPo12 (pGEc47∆B) on alkanols (Sigma-113 
Aldrich), cells from a LB pre-culture were washed three times with M9 medium and used 114 
to inoculate the 5 ml M9 main cultures in 14 ml tubes (Greiner) to an OD=0.1, then 115 
grown at 30°C with continuous shaking. Libraries of P. putida GPo12 (pGEc47∆B) 116 
strains expressing AlkB or CYP153A6 variants were pre-cultured on E2 minimal media 117 
plates with antibiotics and 0.2% (w/v) citrate as carbon source, then enriched for 118 
improved strains through continuous growth in liquid E2 minimal medium with small 119 
chain-length alkanes as the sole carbon source, as described above.  120 
Transformation, cloning, and mutagenesis.  E. coli DH5α strains used for 121 
plasmid amplification were transformed by electroporation (23), E. coli BL21(DE3) 122 
(Novagen) used for protein expression by heat shock according to the manual, and P. 123 
putida GPo12 (pGEc47∆B) strains by triparental mating with the appropriate E. coli 124 
DH5α donor and E. coli CC118 (pRK600) mediator strain (6). Plasmids 125 
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pCom8_cyp153A6 and pCom10_alkB were obtained from the B. Witholt laboratory 126 
(now retired), ETH Zurich. Sequencing of pCom8_cyp153A6 revealed it to be missing 127 
the first 9 nucleotides of the coding sequence of the monooxygenase gene compared to 128 
the published sequence (9). The CYP153A6 parent enzyme and its variants are therefore 129 
three N-terminal amino acids shorter than the published sequence, but are otherwise 130 
identical and obviously functional. 131 
Mutagenesis of pCom plasmids was performed in E. coli XL1-Red strains 132 
according to the manual (Stratagene), and in E. coli JS200 (pEP Pol I), as described 133 
previously (3). Mutated alkB genes or cyp153A6_fdrA6_fdxA6 operons were cloned into 134 
the original pCom10 or into pCom8* plasmids as EcoRI-HindIII or KpnI digested 135 
fragments, respectively. Restriction enzymes were obtained from Roche Molecular or 136 
New England Biolabs. Plasmid pCom8_alkBFG was constructed by amplifying the 137 
alkBFG operon from the plasmid pblaP4_alkJBFG-luxAB (19) using the primers 138 
alkBFG_1 (GATCTACATATGCTTGAGAAACACAGAGTTCTGGATTC) and 139 
alkBFG_2 (GATCTACCCGGGTCACTTTTCCTCGTAGAGCACATAGTC) in a 140 
standard PCR method. The resulting fragment was cloned into the pCom8 vector using 141 
the NdeI and XmaI restriction sites introduced by the primers. The resulting plasmid was 142 
digested with SpeI, and the resulting alkB-containing 3.7 kb fragment was replaced with 143 
the appropriate fragment from SpeI-digested pCom10_alkB, pCom10_alkB-BMO1, and 144 
pCom10_alkB-BMO2 by cloning, resulting in pCom8_alkBFG, pCom8_alkB-145 
BMO1_alkFG, and pCom8_alkB-BMO2_alkFG. Successful cloning was verified by 146 
sequencing.   147 
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Protein expression and bioconversions. E. coli BL21(DE3) cells expressing 148 
AlkB variants were pre-cultured in LB medium at 37°C with 250 rpm shaking for 24 h. 149 
120 ml LB cultures in 1000 ml flasks were inoculated to an OD600 of 1.0 and grown at 150 
37°C, 250 rpm, for 2.5 h. The cultures were then set to 25°C at 200 rpm and induced with 151 
0.4 mM dicyclopropylketone (Sigma-Aldrich) after 30 min. The cultures were 152 
centrifuged (10 min, 3300 g, room temperature) 20 h later and the cell pellets 153 
resuspended in an equal volume of 100 mM KPi buffer (pH=7.0). For cell dry weight 154 
(cdw) determination, 10 ml cell suspensions were washed once with distilled water and 155 
the cell pellets dried for 3 days at 80°C. For bioconversion experiments with liquid 156 
alkanes, 250 µl of the alkane and 1% (v/v) glycerol were added to 1 ml cell suspension in 157 
a glass vial (Kimax), capped, and incubated at a 60° angle, 25°C, 200 rpm. After 60 min, 158 
reactions were stopped by addition of 200 µl 1 N HCl. Pentane bioconversion samples 159 
were then left open at 60°C for 1 h to evaporate the substrate and subsequently pelleted, 160 
filtered, and subjected to GC analysis. Octane bioconversion products were extracted by 161 
adding 250 µl hexane, vortexing for 30 s, and centrifuging at 14000 rpm for 10 min. 162 
Alkanols were then detected in the top organic layer. 163 
For bioconversions of gaseous alkanes, 80 ml cell suspension and 15 µl antifoam 164 
(Sigma-Aldrich) were stirred in a 100 ml bioreactor (Ochs-labor) at 25°C. Propane or 165 
butane was mixed in a 1:3 ratio with air and the mixture fed to the cells at an inlet gas 166 
flow rate of approximately 10 l h-1. The reaction was started by addition of glycerol to a 167 
final concentration of 1% (v/v). After 30 min, 1 ml samples were taken from the cell 168 
suspension as well as from the wash fraction of a bubbler installed downstream of the 169 
bioreactor, combined, centrifuged, filtered and subjected to GC analysis. 170 
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Bioconversions with CYP153A6 variants were conducted as described above, 171 
with the following modifications: cells induced for expression of CYP153 were grown in 172 
modified M9 medium with 1.5% yeast extract for 14 h, and the buffer used for 173 
bioconversions was modified M9 medium prepared without nitrogen. Gaseous alkane and 174 
air were introduced at 1:1 (v/v) through a gas dispenser. Bioconversions of liquid and 175 
gaseous alkanes were started by addition of 20 mM glucose and stopped after 60 min. 176 
Concentration of properly-folded P450 protein was determined from the CO-difference 177 
spectrum of 5× concentrated cell-free extract after sonication, removal of cell debris, and 178 
bubbling CO into the sample. Addition of reducing agent to a concentrated cell-free 179 
extract was not necessary, and in fact decreased CO binding. To assess P450 stability, 180 
CO-binding studies were performed on aliquots of cell-free extract that had been stored at 181 
25°C for up to 24 hours.  182 
 183 
Results 184 
 185 
P. putida GPo12 (pGEc47∆B) grows on short-chain 1-alkanols but not the 2-186 
alkanols. P. putida GPo12 (pGEc47∆B) was shown in previous studies to grow on 187 
medium chain-length alkanols like 1-octanol and on the corresponding alkane only when 188 
complemented by a terminal alkane hydroxylase (26, 31). To determine whether this 189 
strain could be used to select or screen for improved terminal alkane hydroxylation 190 
activity, we tested its ability to grow with the primary and secondary C1-C8 alkanols as 191 
sole carbon sources (Fig. 1). No growth was observed on any of the secondary alcohols 192 
or on methanol during an 18 day period. Ethanol, 1-propanol and 1-butanol supported 193 
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relatively strong growth, comparable to that of the positive control grown on glucose. 194 
Slow growth was observed on 1-pentanol, 1-hexanol and 1-octanol. The results indicated 195 
that the terminal hydroxylation products of all the short-chain n-alkanes except for 196 
methane are readily utilized as carbon sources, while subterminal oxidation products (the 197 
sec-alkanols) are not. Thus this strain should be suitable for growth-based screening and 198 
selection for terminal hydroxylation of long, medium, and short chain-length alkanes.   199 
 200 
Creation of gene libraries through random plasmid mutation. It was not 201 
efficient to use error-prone PCR to randomly mutate the target genes, as cloning of PCR 202 
products into the pCom vector yielded fewer than 2000 transformants, much less than the 203 
hundreds of millions of mutants that can be evaluated in principle using a growth 204 
selection.  Mutant libraries were therefore constructed by complementing P. putida 205 
GPo12 (pGEc47∆B) strains with randomly-mutated plasmids encoding AlkB or 206 
CYP153A6. The drawbacks of including mutations that affect the vector (antibiotic 207 
resistance and origin of replication) rather than just the inserted genes are compensated 208 
for by the large size and ease of library construction. Mutator strains were used to 209 
generate the plasmid libraries, and to increase diversity both available mutator strains 210 
were used, Escherichia coli XL1Red (Stratagene) and E. coli JS200 pEP Pol I (4). E. coli 211 
XL1Red has deficiencies in the DNA repair mechanism that lead to a 5000 fold increase 212 
in the general mutation rate (11) (Stratagene manual).  E. coli JS200 pEP Pol I expresses 213 
an engineered mutator DNA polymerase I, which mainly amplifies plasmid DNA, with 214 
lower reliability, thus introducing mutations in the plasmid DNA (4). The nucleotide 215 
mutation level in XL1Red after two weeks of continuous culturing was approximately 216 
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0.1/kb, while four rounds of mutation in JS200 pEP Pol I yielded up to 0.4/kb. Cultures 217 
of both mutator strains were combined and the mutated plasmids were transformed into 218 
P. putida GPo12 (pGEc47∆B) through triparental mating with the helper strain E. coli 219 
CC118 (pRK600) (31). The growth selection was performed by culturing the resulting 220 
strain library in minimal medium with an alkane as sole carbon source for up to three 221 
weeks, as described in Materials and Methods. 222 
 223 
P. putida GPo12 (pGEc47∆B) strains grow faster on butane when 224 
complemented with evolved AlkB and CYP153A6 variants. A mixed culture 225 
containing alkane hydroxylase variants will become enriched in strains best adapted to 226 
use alkanes as their sole carbon source. However, not only can beneficial mutations in the 227 
hydroxylase gene lead to improved growth, but adaptations of the host and vector will do 228 
so as well. For P. putida GPo12 (pGEc47∆B) complemented by CYP153 genes, it had 229 
been observed that the host had to be adapted through prolonged cultivation on alkanes to 230 
obtain significant growth on these substrates (31), without any mutations occurring in the 231 
cyp153 genes themselves. To test whether host adaptation was also occurring in our 232 
experiments, 21 single colonies obtained from the first round of enrichment cultures were 233 
compared to the parent strain in plate growth tests (data not shown). Solid media growth 234 
tests were chosen over liquid media due to the growth instability of liquid minimal media 235 
cultures of P. putida GPo12 (pGEc47∆B), which often showed different growth rates 236 
between replicates or, occasionally, failure to grow at all. The host, vector, and operons 237 
of the best mutants were analyzed individually by comparing them in growth tests to their 238 
wild-type counterparts. To identify and analyze potentially adapted hosts, the adapted 239 
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recombinant strain was cured of the plasmid and transformed with the appropriate wild-240 
type plasmid. Adapted vectors were isolated from the strains and the alkB gene or 241 
cyp153A6_fdrA6_fdxA6 operon was replaced with the wild-type sequence by cloning, 242 
before being mated into the wild-type host. Furthermore, potentially improved 243 
hydroxylase genes were recloned into a wild-type vector and transferred into a wild-type 244 
host.  245 
Comparison of all the resulting strains in growth assays led to the identification of 246 
several improved hosts and vectors.  Strain Pcyp1, an adapted P. putida GPo12 247 
(pGEc47∆B), showed faster growth on pentane than its parent when complemented by 248 
the wild-type pCom8_cyp153A6 plasmid. Further adaptation of Pcyp1 led to Pcyp2, 249 
which again grew faster on pentane. Similarly, strain Palk1 showed improved growth on 250 
propane and butane when transformed with wild-type pCom10_alkB. For the CYP153A6 251 
system, adapted plasmid pCom8* enabled faster growth of P. putida GPo12 (pGEc47∆B) 252 
on pentane, even when it contained the wild-type operon. Sequencing showed no 253 
mutation of the cyp operon in pCom8*_cyp153A6 or in the sequence 500 nucleotides up- 254 
and downstream from the operon. For the AlkB system, no improved vectors were 255 
obtained. The adapted host and vector components were specific for the particular system 256 
used, i.e. strain Palk1 did not show improved growth on short chain-length alkanes 257 
compared to the wild-type host when complemented with CYP153A6. Likewise, Pcyp1, 258 
Pcyp2  and pCom8* were only adapted for their specific systems. The nature of the 259 
mutations and how they benefit growth on short-chain alkanes is unknown.  260 
In addition to creating these adapted hosts and plasmid, the first rounds of in vivo 261 
directed evolution generated enzyme variants AlkB-BMO1 (butane monooxygenase) and 262 
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CYP153A6-BMO1, both of which conferred improved growth on butane. Sequencing 263 
revealed a single nucleotide mutation in each: mutation of the codon cta to gta led to the 264 
single amino acid substitution L132V in AlkB-BMO1 and, through a gca to gta change, 265 
the substitution A94V in CYP153A6-BMO1 (A97V in the published sequence (9), see 266 
Materials and Methods).  267 
All the adapted components were combined and evaluated in plate growth tests 268 
(Table 2, Fig. 2). Palk1 expressing AlkB-BMO1 showed a significant increase in rate of 269 
growth on butane compared to Palk1 expressing wild-type AlkB. In contrast, growth rates 270 
on pentane and octane were reduced. No significant growth improvement on propane was 271 
observed, and neither enzymed supported growth on ethane.  These results suggest that 272 
the L132V mutation in AlkB-BMO1 specifically improves activity towards butane. A 273 
similar result was found for Pcyp2 (pCom8*_cyp153A6-BMO1) recombinants, which 274 
grew more slowly on octane than Pcyp2 (pCom8*_cyp153A6), but faster on pentane. The 275 
CYP153A6-BMO1 variant also supported growth on butane, which wild-type 276 
CYP153A6 does not. Thus the A94V mutation appears to specifically enhance activity on 277 
the smaller alkanes. 278 
Plasmids pCom8*_cyp153A6-BMO1 and pCom10_alkB-BMO1 were subjected 279 
to a second round of mutagenesis and mated into Pcyp2 and Palk1, respectively. A 280 
further-improved AlkB monooxygenase, AlkB-BMO2, was obtained after enrichment 281 
and screening. Sequencing revealed a total of three nucleotide mutations, all resulting in 282 
amino acid substitutions in AlkB-BMO2: V129M (gtg to atg), L132V (cta to gta), and 283 
I233V (atc to gtc). To ensure comparison in identical genetic backgrounds, the mutated 284 
gene was recloned into a wild-type pCom10 vector, mated into fresh Palk1, and 285 
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compared in growth tests to Palk1 expressing AlkB wild-type and AlkB-BMO1 (Table 2, 286 
Fig. 2). Compared to its parent AlkB-BMO1, AlkB-BMO2 performed even better in 287 
growth complementation studies with butane. Growth on pentane and octane was also 288 
improved, but was still inferior to that obtained with the wild-type enzyme. Thus, the 289 
mutations V129M and I233V improved the overall activity of AlkB-BMO2 compared to 290 
its parent AlkB-BMO1. Enrichment and screening yielded no additional improvement in 291 
the CYP153A6 system, 292 
 293 
Whole-cell bioconversions in E. coli confirm improved performance of AlkB-294 
BMO1, -BMO2, and CYP153A6-BMO1 for conversion of butane to 1-butanol. In 295 
order to quantify the effects of the mutations on enzyme performance, whole-cell 296 
bioconversions were performed using growth-arrested E. coli BL21(DE3) cells 297 
containing the CYP153A6 variants expressed from pCom8*. Although pCom plasmids 298 
are not efficient expression platforms, we nonetheless observed CYP153A6 expression in 299 
E. coli, as indicated by the CO difference spectral peak at 450 nm (Fig. 3). In contrast, no 300 
450 nm signal was observed for cells harboring the empty pCom8* plasmid. Cytochrome 301 
P450s are notoriously difficult to express, and it has been reported that the CO binding 302 
activity of CYP153A6 is lost shortly after cell disruption at room temperature, even when 303 
the enzyme is isolated from its native host (32). However, we found CYP153A6 to 304 
express well in E. coli DH5α and show a stable CO difference spectrum for hours at 305 
room temperature, if protease inhibitor was added before cell disruption (data not shown). 306 
Using E. coli BL21(DE3) cells, which are deficient in the Lon and OmpT proteases, 307 
eliminated the need to add protease inhibitor for stable CYP153A6 expression. Cell-free 308 
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extract from these cultures, expressing CYP153A6 or CYP153A6-BMO1, retained full 309 
CO-binding capacity for 24 h when stored at 25°C.  At 45°C, CO-binding capacity 310 
decreased with time, showing a half-life of 638 min (±68 min) for cell-free extract 311 
containing CYP153A6-BMO1 and 367 min (±58 min) with CYP153A6.  312 
The typical concentration of folded CYP153A6 in the cell suspensions used for 313 
bioconversions was 0.1-0.2 µM, with CYP153A6-BMO1 usually expressing ~20% less 314 
than its parent CYP153A6 (Fig. 3). For both enzymes, we observed no significant 315 
decrease in apparent P450 concentration after the 60 min bioconversion reactions (data 316 
not shown). Bioconversion studies showed significantly altered activity and selectivity 317 
for CYP153A6-BMO1 that closely followed its growth complementation performance 318 
(Fig. 4A). Control bioconversions performed under the same conditions but using 319 
transformants of empty pCom8* vector did not produce alkanols (data not shown). 320 
Butane bioconversions yielded an averaged total of 393 µM 1-butanol in the aqueous 321 
phase after 60 minutes with CYP153A6-BMO1, versus 277 µM with wildtype 322 
CYP153A6 (Table 3). From the concentration of product formed divided by the 323 
concentration of folded P450, the average turnover rate of CYP153A6-BMO1 in 1-324 
butanol production was 49 min-1, a 75% increase compared to 28 min-1 for CYP153A6. 325 
Interestingly, the selectivity for terminal hydroxylation also increased with the variant, 326 
from 78% to 89% of total alkanol product. The A94V mutation also improved activity 327 
and selectivity for conversion of pentane to 1-pentanol, but had the opposite effect with 328 
propane and octane. 329 
Since E. coli cells expressing only AlkB showed no product formation, 330 
bioconversions were performed using cells transformed with pCom8_alkBFG. Minak-331 
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Bernero et al. (19) demonstrated that the AlkBFG system including the monooxygenase 332 
AlkB and the non-essential and essential rubredoxins AlkF and AlkG is functional in E. 333 
coli, without the need for the rubredoxin reductase AlkT. Results of bioconversions using 334 
AlkB, AlkB-BMO1 and AlkB-BMO2 (Fig. 4B) showed that the activity of the variants 335 
was greater than that of wild-type on butane, the substrate used for in vivo evolution, 336 
while performance on pentane and octane was decreased. The evolved variants also 337 
showed increased activity on propane, the only change in activity that was not reflected 338 
in a similar observable change in growth complementation performance.  339 
In 30 minutes, butane bioconversions utilizing AlkB, AlkB-BMO1 or AlkB-340 
BMO2 produced on average 630 µM, 1030 µM, and 1580 µM 1-butanol in the aqueous 341 
phase, respectively. The dry cell weights of the cell suspensions used for the 342 
bioconversions ranged from 3.0 to 4.0 g/L. The activities in µmol 1-butanol min-1 g cdw-1 343 
thus increased from 6.1 to 9.5 and 15.7 units, respectively. Bioconversions with AlkB 344 
variants were highly regioselective, producing no detectable 2-alkanol from propane and 345 
pentane, and very little 2-alkanol from butane and octane (Table 3). 346 
 347 
Discussion 348 
 349 
Advantages and drawbacks of in vivo evolution of terminal alkane 350 
hydroxylases.  An in vivo directed evolution system with selection for terminal alkane 351 
hydroxylase activity has been developed and applied to engineering enzymes from the 352 
AlkB and CYP153 families.  The goal of this work was to increase activity on short-chain 353 
alkanes while maintaining these enzymes’ remarkable preference for the 354 
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thermodynamically-disfavored terminal position, thereby taking a first step towards 355 
engineering small-alkane hydroxylases that can be expressed in a recombinant bacterial 356 
host amenable to further engineering.  357 
Evolution in vivo using a growth selection enables searches through as many as 358 
108 mutants in a simple flask culture while exerting selection pressure for many useful 359 
enzyme characteristics simultaneously (substrate specificity, regioselectivity, specific 360 
activity, coupling of cofactor utilization to product formation, expression level). In this 361 
particular case, the Pseudomonas host used for the directed evolution only utilizes 362 
primary alcohols, allowing selection directly for terminal hydroxylation. This is the only 363 
method we know of for efficient, high throughput selection or screening of this important 364 
activity. Previous efforts to engineer P450 BM3 or P450cam for alkane hydroxylation 365 
resulted in enzyme variants mainly targeting subterminal positions (36, 8). The present 366 
system promises to be useful for the directed evolution of a range of alkane hydroxylases, 367 
since P. putida GPo12 (pGEc47∆B) can be complemented for growth on alkanes by 368 
many different AlkB and CYP153 genes (26, 31). Furthermore, growth tests showed that 369 
the host can utilize 1-alkanols down to ethanol, potentially enabling enrichment for 370 
activity on alkanes as small as ethane. 371 
This growth selection system could handle a mutation rate perhaps ten times 372 
greater than the 0.1 to 0.4 nucleotide changes per kb obtained using the mutator strains. 373 
The P. putida GPo12 organism and the components used in this study, however, are 374 
somewhat difficult to handle with regards to growth stability, expression, mutation rates, 375 
cloning and transformation efficiency. Furthermore, in vivo evolution also has limits for 376 
identifying moderately improved variants, since enrichment to pure culture may require 377 
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weeks or months of continuous culturing, depending on the actual doubling time on a 378 
given substrate and the level of improvement over the parent. This makes the stepwise 379 
accumulation of small improvements more challenging.  380 
 381 
AlkB enables P. putida GPo12 (pGEc47∆B) to grow on propane and butane, 382 
and can be improved in this function. Our results prove that propane and butane are 383 
substrates of AlkB from P. putida GPo1, verifying earlier assumptions (12). No growth 384 
complementation was observed on ethane, and the E. coli system utilized in the 385 
bioconversion reactions could not be used to determine whether ethane is converted to 386 
ethanol by AlkB variants, because the glycerol added to allow NADH regeneration was 387 
fermented to ethanol by the E. coli BL21(DE3) host. Quantification of AlkB activity on 388 
ethane would require purification and reconstitution of AlkB and its electron transport 389 
system or genetic modification of the strain used for whole-cell bioconversions. 390 
Second-generation variant AlkB-BMO2 supported significantly better growth and 391 
butane bioconversion,more than double that of wild-type AlkB. Although specific 392 
activity (mol product/ mol enzyme/ minute) could not be determined for the AlkB 393 
variants, absolute 1-butanol production rates in bioconversion reactions were 394 
significantly higher for the AlkB-BMO2 system (up to 1.6 mM in 30 min) than for 395 
CYP153A6-BMO1 (0.4 mM in 60 min). The higher product formation rate with the AlkB 396 
system was surprising, in view of the fact that it relied on a non-native E. coli host 397 
reductase, while the CYP153A6 system contained the complete native electron transfer 398 
chain with its ferredoxin and ferredoxin reductase. In earlier studies, AlkB activity in E. 399 
coli cells increased from 3 U to 20 U when the specific reductase, encoded by alkT, was 400 
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present (29). However, the significantly higher E. coli whole-cell bioconversion rates 401 
with AlkB variants did not translate into better growth complementation of adapted P. 402 
putida GPo12 (pGEc47∆B) strains. It is known that AlkB expresses two- to tenfold better 403 
in E. coli than in P. putida. On the other hand, AlkB has a five- to six-fold higher specific 404 
activity in P. putida (28). Thus a possible explanation for the growth complementation is 405 
that the CYP153 variants express better or have a higher specific activity in P. putida 406 
compared to the AlkB variants. Furthermore, the twice-adapted host Pcyp2 might contain 407 
chromosomal improvements that are able to compensate for the lower apparent butane 408 
oxidation activity of CYP153A6-BMO1 and thus achieve the same growth rate on butane 409 
as Palk1 expressing AlkB. 410 
Although no crystal structures are available for any enzyme of the AlkB family, a 411 
topology model (34, 35) has been published. Mapping of the evolved AlkB variant 412 
mutations on that model (Fig. 5) showed that two of the three mutations generated in 413 
AlkB-BMO2, V129M and L132V, are close to the histidine-containing sequence motif A 414 
(H138EXXHK143), which is one of four highly conserved histidine-containing motifs in 415 
AlkB believed to coordinate the Fe ions and presumed to be part of or close to the active 416 
site (24, 35). Thus, a direct effect of V129M and L132V on the active site of AlkB seems 417 
possible. The third amino acid substitution, I233V, is located close to the periplasm in the 418 
sixth predicted transmembrane domain, distant from the active site. 419 
 420 
CYP153A6-BMO1 constitutes the first functional butane monooxygenase of 421 
the CYP153 family. Evolved CYP153A6-BMO1 is the first CYP153 shown to 422 
hydroxylate butane and enable its host to grow on this short chain-length alkane. The 423 
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gaseous alkanes are usually processed by distinct, specialized enzymes, like the di-iron 424 
methane and butane monooxygenases (30) that are unrelated to the cytochrome P450s. 425 
Complementation of P. putida GPo12 (pGEc47∆B) with various CYP153 wild-type 426 
enzymes resulted in growth on alkanes ranging from pentane to decane (31), but never on 427 
butane (our own, unpublished results). And, until now, biotransformations using CYP153 428 
enzymes have only demonstrated activity for hexane and longer alkanes  (14, 9, 10). Here 429 
we demonstrated that CYP153A6 wild-type and CYP153A6–BMO1 act on butane and 430 
even propane, but only the BMO1 variant complemented growth of Pcyp2 on butane. The 431 
activity for 1-butanol formation of 49 min-1 (0.8 s-1) measured in CYP153A6-BMO1 432 
assays is still less than that reported for the methane monooxygenase from Methylosinus 433 
trichosporium OB3b  (8.8 s-1 (7)), although these values were generated under very 434 
different reaction conditions.  Not only does CYP153A6-BMO1 exhibit increased total 435 
activity on butane compared to its wild-type parent, but its preference for terminal 436 
hydroxylation also increased, resulting in only 11% 2-butanol formation compared to 437 
22%  for the wild-type enzyme. CYP153A6-BMO1 was converted into a genuine butane 438 
monooxygenase by in vivo directed evolution.  439 
CYP153A6-BMO1 contains a single amino acid substitution, which corresponds 440 
to A97V in the published structure model (9). This mutation, which has a slightly 441 
negative effect on expression level (the CYP153A6-BMO1 variant usually showed ~80% 442 
of the CO-binding activity of wildtype) stabilized CYP153A6 and nearly doubled its half-443 
life at 45°C. However, this effect is unlikely to explain the higher observed bioconversion 444 
rates, since both enzymes were stable at 25°C, and no loss of folded P450 was observed 445 
at the end of the bioconversions. These findings argue for a direct positive effect of the 446 
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A97V substitution on the butane hydroxylation activity.  Based on a proposed model of 447 
CYP153 (9), however, A97 is predicted to be located in a loop distant from the active 448 
site, pointing towards the protein surface and not the substrate channel (Fig. 5).  Why the 449 
activity of CYP153A6 and CYP153A6-BMO1 on propane, as observed in the E. coli 450 
bioconversion experiments, is not accompanied by growth complementation of Pcyp2 on 451 
propane remains unknown.  A minimum activity required for growth may not have yet 452 
been reached.  It is also possible that the substrate is not available at sufficient 453 
concentration or is toxic. 454 
The appearance of improved variants of AlkB and CYP153A6 demonstrated that 455 
in vivo evolution in adapted P. putida GPo12 (pGEc47∆B) can be applied to very 456 
different monooxygenase enzymes. Despite the higher absolute activity and better 457 
regioselectivity of AlkB variants in the bioconversion experiments, the CYP153A 458 
enzymes nonetheless offer some important advantages for further engineering. CYP153 459 
enzymes are soluble, and accurate determination of functional expression and 460 
concentration is easier due to observable CO binding. Furthermore, CYP153 proteins 461 
have been shown to function in whole-cell bioconversions as single-component, self-462 
sufficient fusion proteins with the P450RhF reductase domain (14, 21) as well as with the 463 
CYP102A reductase domain (our own, unpublished results). Further directed evolution of 464 
terminal alkane hydroxylases like AlkB or CYP153A6 should help us to better 465 
understand and utilize their remarkable catalytic activities. 466 
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Figure legends 583 
 584 
FIG. 1. Growth of P. putida GPo12 (pGEc47∆B) with primary and secondary 585 
linear short and medium chain-length alkanols. Optical density at 600 nm (OD600) of the 586 
cultures was measured after 18 days growth in liquid M9 minimal media with 0.5% (v/v) 587 
primary (CX-1ol, X=number of carbon atoms) or secondary (CX-2ol) alcohols as carbon 588 
source dissolved in a 5% (v/v) organic layer of heptamethylnonane. Alcohols smaller 589 
than five carbon atoms were added without organic solvent. Cultures with 0.5% (w/v) of 590 
glucose or no added nutrient served as controls. 591 
 592 
FIG. 2. Growth of P. putida GPo12 (pGEc47∆B) strains on alkanes. (A) Strains 593 
of adapted P. putida GPo12 (pGEc47∆B) complemented by an empty plasmid, or 594 
expressing CYP153A6 wild-type or CYP153A6-BMO1 (left, middle, and right section) 595 
were grown for five days with butane as sole carbon source. (B) Growth of adapted P. 596 
putida GPo12 (pGEc47∆B) strains complemented by an empty plasmid, expressing the 597 
AlkB wild-type, or its variants -BMO1 and -BMO2, on butane after two days. 598 
 599 
FIG. 3. CO difference spectra of lysed E. coli BL21(DE3) cell suspensions. E. 600 
coli BL21(DE3) cultures expressing CYP153A6 or CYP153A6-BMO1 were 601 
concentrated 5:1 in buffer, and UV-VIS spectra were obtained from the cell-free extracts 602 
after CO saturation. The peaks correspond to 0.21 µM and 0.17 µM folded P450 for the 603 
CYP153A6 and CYP153A6-BMO1 samples, respectively. Cells carrying the empty 604 
vector treated in the same way served as the negative control.  605 
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 606 
FIG. 4. Bioconversions of alkanes to 1- and 2-alkanols. Whole cell 607 
bioconversions were carried out with at least two replicates using resting E. coli 608 
BL21(DE3) cells after expression of (A) CYP153A6 and (B) AlkB variants. Relative 609 
enzymatic activity in the aqueous cell suspension was calculated from the alcohol product 610 
formed per minute and (A) enzyme concentration or (B) total cell dry weight. The lower 611 
graphs represents relative activities for 1-alkanol, the upper part for 2-alkanol production 612 
(if detected). Sole added carbon sources were propane (C3), butane (C4), pentane (C5), 613 
and octane (C8). White graphs depict wild-type activity, light gray the BMO1, and dark 614 
grey the BMO2 variant activities. 615 
 616 
FIG. 5. Models for (A) AlkB and (B) CYP153A6. (A) Topology model of AlkB, 617 
taken from van Beilen et al. (35). Variants AlkB-BMO1 and AlkB-BMO2 with increased 618 
activity on butane carry L132V and V129M+L132V+I233V mutations (marked by white 619 
circles), respectively. Amino acids 129 and 132 are close to the first of four histidine-620 
containing sequence motifs (A-D) that contribute to coordinating the Fe ions. Position 621 
233 is located in the periplasmic end of the sixth transmembrane domain (numbers 1-6). 622 
(B) CYP153A6 structural model with bound substrate octane (spheric object), modified 623 
from Funhoff et al. (9). CYP153A6-BMO1 carries a mutation corresponding to A97V in 624 
the model.  625 
ACC
EPT
ED
 30 
TABLE 1. Strains and plasmids used or constructed in this work.  626 
 627 
Strain or plasmid 
 
Relevant genotype or characteristics Reference 
or source 
Strains  
 
E. coli CC118 
(RK600)  
Helper strain for triparental mating 6 
E. coli DH5α Cloning strain Invitrogen 
E. coli JS200         
(pEP Pol I) 
Mutator strain Addgene, 
3 
E. coli XL1-Red Mutator strain Invitrogen 
P. putida GPo12 
(pGEc47∆B) 
P. putida GPo1 cured of the OCT plasmid, 
transformed with pGEc47∆B: Contains all genes 
necessary for growth on alkanes, except for alkane 
hydroxylase gene 
26 
Palk1 P. putida GPo12  (pGEc47∆B) adapted to growth on 
gaseous alkanes with pCom10_alkB 
This 
study 
Pcyp1 P. putida GPo12  (pGEc47∆B) adapted to growth on 
gaseous alkanes with pCom8_cyp153A6 
This 
study 
Pcyp2 Pcyp1 further adapted to growth on gaseous alkanes 
with pCom8*_cyp153A6-BMO1 
This 
study 
   
Plasmids   
pCom8 Broad-host-range expression vector with PalkB; Gmr 
oriT alkS 
25 
pCom8* pCom8 vector adapted for improved 
complementation for small chain-length alkane 
dependent host growth 
This 
study 
pCom10 Broad-host-range expression vector with PalkB; Kanr 
oriT alkS 
25 
 628 
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TABLE 2. Relative growth of adapted P. putida GPo12 (pGEc47∆B) strains, expressing 629 
CYP153A6 and AlkB variants, on minimal media plates with alkanes as sole carbon 630 
source. 631 
 632 
Days required for growth to a full lawn with selected carbon source Complementing 
alkane monooxygenase Ethane Propane Butane Pentane Octane 
AlkB wild-type NG 5 5 3 2 
AlkB-BMO1 NG 5 3 6 7 
AlkB-BMO2 NG 5 2 4 8 
CYP153A6 wild-type NG NG NG 2 2 
CYP153A6-BMO1 NG NG 5 1.5 5 
NG: No growth detected during three week observation.  
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TABLE 3. Absolute product concentrations after bioconversions in resting E. coli 633 
BL21(DE3) cells. 634 
 635 
 Total hydroxylated product in [µM]* 
substrate** CYP153A6 CYP153A6-BMO1 AlkB AlkB-BMO1 AlkB-BMO2 
Propane 421 (59%) 244 (68%) 625   (0%) 1048 (0%) 973   (0%) 
Butane 356 (22%) 439 (11%) 639   (1%) 1045 (1%) 1586 (1%) 
Pentane 260 (62%) 374 (49%) 606   (0%) 294   (0%) 317   (0%) 
Octane 78   (3%) 69   (46%) 1122 (9%) 487   (2%) 308   (1%) 
 636 
*Values in parentheses are the percentage of 2-alkanol in the total hydroxylated product. Only 1- and 2-637 
alkanols were formed in detectable amounts. 638 
**Bioconversions with propane and butane were performed in a bioreactor for 30 min with AlkB variants 639 
and 60 min with CYP153A6 variants. Bioconversions with pentane and octane were shaken in a glass vial 640 
for 60 min for all enzymes.  641 
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